������Ƶ

Christopher Stokes was appointed President and General Manager (GM) of Eli Lilly and Company UK, Ireland & Northern Europe in July 2024. Christopher leads Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Obesity, Oncology, Immunology and Neuroscience. Christopher joined the UK from his previous role as General Manager of Lilly Korea, where he led the Korean affiliate to strong business results driven by new product growth.

Christopher has been at Lilly since 2008 and has held roles as GM of Lilly South Africa and Sub-Saharan Africa, and COO of Lilly USA. He has built a reputation for expertise in the global regulatory landscape and an unfaltering commitment to patient access to innovative medicines to enhance health. He has a “better to best” mindset and brings a focus on delivering results while building and engaging strong teams with high integrity. Christopher holds a Bachelor’s degree from George Mason University and a Master’s in Public Administration from Indiana University-Bloomington.